
Additional investment from existing investors to further strengthen the business base
(Head office: Taito-ku, Tokyo; Representative Directors and CO-CEOs: Hiroatsu Hayashi and Rieko Akiyama), a University of Tokyo-based startup for longevity and immortality, raised 100 million yen on December 9, 2025, through J-KISS type stock acquisition rights underwritten by existing investors. The company also received a cash prize of 200,000 yen in the "Healthcare Venture Award" competition co-sponsored by the Japan Anti-Aging Society and the Medical Association of Japan, bringing the total amount raised to approximately 286 million yen.
This funding by J-KISS is an extension of the seed round and was made possible by additional investment from a prominent private investor (LP) who has supported TIME TRAVELER since the early days of the company.
We take this as recognition of our efforts and achievements to date, as well as a reaffirmation of our expectations for future growth.
Main areas of use of funds raised this time
0Strengthen basic technologies and intellectual property related to aging and cancer-related diseases
Recruitment and training of researchers and business development personnel to promote drug discovery research
Strengthen R&D infrastructure, including the development of a 0 evaluation system and expansion of experimental equipment
Development of research infrastructure and data acquisition system for the next phase of development
0 Construction cost for head office and factory relocation
0Strengthen manufacturing system and public relations activities for the "exofull" brand of plant-derived exosome supplements
Research and development and PoC construction for the next product (drug discovery and wellness area)
TIME TRAVELER is committed to research and value creation to solve fundamental issues such as aging and cancer-related diseases, with the vision of "turning on the light of hope in unexplored areas through the science of cellular time.
TIME TRAVELER will further promote the social implementation of research results toward the realization of a healthy and long-lived society, and aim for sustainable growth together with investors who share and support TIME TRAVELER's vision.
TIME TRAVELER|Company Profile
| name of company | TIME TRAVELER Corporation |
| Establishment | Jan. 2024 |
| Location | 2F Kojima Bldg., 2-3-2 San-suji, Taito-ku, Tokyo |
| representative | Representative Director, CO-CEO Hiro Atsushi Hayashi / Rieko Akiyama |
| Business Overview | Drug Discovery Health care business utilizing plant-derived exosomes |
| uniform resouce locator | https://www.ttraveler.jp |









